enzymes – IL BIOECONOMISTA

Univar Solutions and Novozymes to expand the partnership into the US and Canadian food ingredients markets

29 April 2021Il BioeconomistaLeave a comment

Univar Solutions Inc., a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, signed a new agreement to expand the partnership into the United States and Canadian food ingredients markets. The new food ingredients agreement takes effect May 1, one month after the companies announced an exclusive agreement expanding the partnership into the United States and Canadian beverage production, homecare, and industrial cleaning markets.

Continue reading →

Univar and Novozymes joined forces to bring more sustainable products to markets

22 March 202120 March 2021Il BioeconomistaLeave a comment

Univar Solutions Inc., a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, signed an agreement, effective April 1, to expand the existing partnership into the U.S. and Canadian homecare, industrial cleaning, and beverages markets. The ongoing and expanding relationship between the two companies demonstrates a shared commitment to providing customers with a portfolio of ingredients designed to help improve product performance and enable solutions that have the potential to bring more sustainable products to the homecare, industrial cleaning and beverages markets through better performing formulations.

Continue reading →

Novozymes enters the biocontrol segment of agriculture with enzyme-based technology

8 February 20216 February 2021Il BioeconomistaLeave a comment

Novozymes, the world leader in biological solutions headquartered in Denmark, is entering the biocontrol segment of agriculture with promising enzyme-based technology – expanding beyond its current base of microbial products and innovation. The new technology – the company claims – has broad potential to control major pests that impact the agricultural industry and are responsible for billions of dollars of damages each year.

Continue reading →

German Biotech company BRAIN AG expands production capacities in Germany and Wales

27 January 202027 January 2020Il BioeconomistaLeave a comment

Jürgen Eck, former CEO of BRAIN AG, Most Innovative Bioeconomy CEO 2018

The BRAIN Group announced an expansion of its production capacities. The installation of new production facilities in both Büttelborn, near Darmstadt, Germany, by WeissBioTech GmbH (WBT) and in Cardiff, Wales, by Biocatalysts Ltd. lays the foundation for future growth.

The companies of the BRAIN Group form a closely knit network in the fields of R&D and production or as suppliers in specific markets. Drawing on the particular competencies of its subsidiaries, BRAIN brings its own innovative research results to market launch and commercializes existing products. By expanding its production capacities, BRAIN reinforces the strategic focus on its product business.

Continue reading →

An exclusive interview with Alex Michine, CEO of MetGen. “Building consumer awareness is key for the expansion of the European bioeconomy”

21 November 201916 November 2019Il Bioeconomista2 Comments

Alex Michine, CEO MetGen, with the Frost & Sullivan Award in London

MetGen is a Finnish company headquartered in Kaarina and founded in 2008 on the core competence of genetic engineering and synthetic biology.

In this exclusive interview with Il Bioeconomista, the CEO, Alex Michine, talks about the achievements and the next steps of the company and gives us his point of view regarding the bioeconomy in Finland and in the European Union.

Interview by Mario Bonaccorso

Continue reading →

Novozymes’ enzymes are available online through Alibaba’s platform

23 May 201922 May 2019Il BioeconomistaLeave a comment

Now, for the first time, Novozymes’ enzymes are available online through Alibaba’s platform for industrial products, 1688.com.

“We want to be a front runner in providing biological solutions online as well as offline. By partnering with Alibaba, we will get even closer to our end-customers, address local market needs faster and explore new application opportunities,” says Thomas Videbæk, COO and Executive Vice President, Novozymes.

Continue reading →

DSM continues to invest in the biofuel industry

29 March 201828 March 2018Il BioeconomistaLeave a comment

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.

Continue reading →

Novozymes launched two new enzymes for the European ethanol market

21 August 2017Il BioeconomistaLeave a comment

Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.

Continue reading →

Novozymes launches an enzyme that adds nearly $1 million per year in revenue for a plant

27 February 2017Il BioeconomistaLeave a comment

Novozymes launched the Spirizyme® T Portfolio, an advanced suite of glucoamylase enzymes with trehalase and other yield enhancing activities that provide the most total sugar conversion in the industry. Trehalase is an enzyme that converts trehalose, a type of sugar that cannot be fermented to ethanol, to glucose, which is easily fermentable.

Continue reading →

The future of Clariant is bio-based

19 April 2016Il BioeconomistaLeave a comment

Clariant new R&D center in Planegg, near Munich

Clariant’s cellulosic ethanol using sunliquid® technology can achieve price competitiveness with sugarcane ethanol pricing in Brazil. To say it is the Swiss chemical company in a note.

Continue reading →